Literature DB >> 32675154

Lessons of the month 3: ST-elevation myocardial infarction and left ventricular thrombus formation: an arterial thrombotic complication of severe COVID-19 infection.

Matthew Fenton1, Seshnag Siddavaram1, Conn Sugihara1, Syed Husain2.   

Abstract

We describe a case of an 82-year-old man who developed an anterior ST-elevation myocardial infarction (STEMI) and left ventricular thrombus while an inpatient following a diagnosis of severe COVID-19 infection (SARS-CoV-2). His D-dimer was significantly elevated at 12,525 ng/mL (normal range <243). He unfortunately died despite management with thrombolysis, warfarin and non-invasive ventilation. This case provides an example of a likely arterial thrombotic complication of severe COVID-19 infection. Clinicians should be aware of this possibility in such patients, with a severely prothrombotic state as a possible underlying aetiology. Further research is required to establish any causative link, pathophysiological mechanisms and whether modification to existing venous thromboembolism prophylaxis strategies may also reduce arterial thrombotic complications of severe COVID-19 infection. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  COVID-19; D-dimer; arterial thrombosis; myocardial infarction; ventricular thrombus

Mesh:

Substances:

Year:  2020        PMID: 32675154      PMCID: PMC7385789          DOI: 10.7861/clinmed.2020-0266

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  6 in total

1.  ST-Segment Elevation in Patients with Covid-19 - A Case Series.

Authors:  Sripal Bangalore; Atul Sharma; Alexander Slotwiner; Leonid Yatskar; Rafael Harari; Binita Shah; Homam Ibrahim; Gary H Friedman; Craig Thompson; Carlos L Alviar; Hal L Chadow; Glenn I Fishman; Harmony R Reynolds; Norma Keller; Judith S Hochman
Journal:  N Engl J Med       Date:  2020-04-17       Impact factor: 91.245

2.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.

Authors:  Thomas J Oxley; J Mocco; Shahram Majidi; Christopher P Kellner; Hazem Shoirah; I Paul Singh; Reade A De Leacy; Tomoyoshi Shigematsu; Travis R Ladner; Kurt A Yaeger; Maryna Skliut; Jesse Weinberger; Neha S Dangayach; Joshua B Bederson; Stanley Tuhrim; Johanna T Fifi
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

3.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

4.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

5.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Authors:  Tao Chen; Di Wu; Huilong Chen; Weiming Yan; Danlei Yang; Guang Chen; Ke Ma; Dong Xu; Haijing Yu; Hongwu Wang; Tao Wang; Wei Guo; Jia Chen; Chen Ding; Xiaoping Zhang; Jiaquan Huang; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  BMJ       Date:  2020-03-26

6.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D A M P J Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-10       Impact factor: 3.944

  6 in total
  3 in total

Review 1.  How to recognize and respond to viral re-positivity and disease relapse in patients with COVID-19.

Authors:  Shiliang Zheng; Caide Liu; Yuhua Chi; Xiaodong Sun
Journal:  J Glob Health       Date:  2021-03-01       Impact factor: 4.413

Review 2.  A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection.

Authors:  Anil Mathew Philip; Lina James George; Kevin John John; Anu Anna George; Jemimah Nayar; Kamal Kant Sahu; Vijairam Selvaraj; Amos Lal; Ajay Kumar Mishra
Journal:  J Clin Transl Res       Date:  2021-11-06

Review 3.  COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.

Authors:  Antonis S Manolis; Theodora A Manolis; Antonis A Manolis; Despoina Papatheou; Helen Melita
Journal:  J Cardiovasc Pharmacol Ther       Date:  2020-09-14       Impact factor: 2.457

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.